1. Home
  2. Browse
  3. Interactions
  4. Bone & Joint

Bone & Joint

46 - 60 of 70 Results
Sort Results:
Commentary: DMARDs in the Treatment of Rheumatoid Arthritis September 2014
Patient Education: What I Need to Know About Benzodiazepines July 2014
Article: fewer red flags when celecoxib (Celebrex) is given to patients with a sulfa allergy February 2014
Commentary: The "Triple Whammy" April 2013
PL Voices: Managing the “Triple Whammy” Interaction April 2013
Article: kidney risks of NSAIDs April 2013
Guideline: 2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia December 2012
Commentary: Proton Pump Inhibitor-Methotrexate Interaction December 2012
PL Voices: Strategies for Managing Gout December 2012
Guideline: 2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis December 2012
Chart: Comparison of Gout Therapies December 2012
Article: PPIs with methotrexate can lead to methotrexate toxicity December 2012
Article: rev up promotion of Uloric (febuxostat) for managing gout December 2012
Guideline: 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis July 2012
Guideline: Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs (2011) July 2012